8-K: Current report
Apr 18 16:11 ET
DEFA14A: Others
Apr 16 16:22 ET
DEF 14A: Definitive information statements
Apr 16 16:16 ET
Teva Pharmaceutical Industries | 8-K: Current report
Jan 31 07:01 ET
Teva Pharmaceutical Industries | 8-K: Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Nov 8, 2023 07:01 ET
Teva Pharmaceutical Industries | 8-K: Current report
Oct 4, 2023 06:05 ET
Teva Pharmaceutical Industries | 8-K: Current report
Sep 28, 2023 16:05 ET
Teva Pharmaceutical Industries | 8-K: Current report
Aug 24, 2023 07:30 ET
Teva Pharmaceutical Industries | 8-K: Current report
Aug 2, 2023 16:16 ET
Teva Pharmaceutical Industries | 8-K: Teva Reports Second Quarter 2023 Financial Results
Aug 2, 2023 07:00 ET
Teva Pharmaceutical Industries | 8-K: Current report
Jun 15, 2023 16:01 ET
Teva Pharmaceutical Industries | 8-K: Current report
Jun 8, 2023 08:30 ET
Teva Pharmaceutical Industries | DEFA14A: Others
May 24, 2023 16:01 ET
Teva Pharmaceutical Industries | 8-K: Current report
May 11, 2023 16:00 ET
Teva Pharmaceutical Industries | 8-K: Teva Reports 2023 First Quarter Financial Results
May 10, 2023 07:01 ET
Teva Pharmaceutical Industries | DEFA14A: Others
Apr 19, 2023 16:12 ET
Teva Pharmaceutical Industries | DEF 14A: Definitive proxy statements
Apr 19, 2023 16:09 ET
Teva Pharmaceutical Industries | 8-K: Current report
Mar 9, 2023 17:17 ET
Teva Pharmaceutical Industries | 8-K: Current report
Mar 3, 2023 07:04 ET
Teva Pharmaceutical Industries | 8-K: Teva Reports 2022 Full year and Fourth Quarter Financial Results
Feb 8, 2023 07:01 ET
No Data
No Data